Chengdu's NetVation DL Forms Partnership with Pfizer

NetVation DL Medicine, a privately held Chengdu biotech, has entered a two-year research collaboration with Pfizer. DL Medicine is a startup financed by HitGen, a company that has formed several drug discovery collaborations with multinational pharmas, and Anlong, a healthcare fund backed by the Chinese Academy of Sciences. DL Medicine will provide drug discovery services to Pfizer. Although terms of the agreement were not disclosed, the companies did say Pfizer has taken a financial stake in DL Medicine. More details.... Stock Symbol: (NYSE: PFE) Share this with colleagues: // //